222
Participants
Start Date
August 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
ENA713
The following strengths of Rivastigmine capsules were provided: Rivastigmine capsule strengths: 1.5mg, 3mg, 4.5mg. The 6mg dose was administered as one 1.5mg capsule and one 4.5mg capsule, and when necessary, the 3mg dose could also be administered as two 1.5mg capsules. Rivastigmine was administered from 3mg/d at baseline. Then dose escalation was made in 3mg/d increments, at a minimun of 4 weeks between dose increases to a maximum dose of 12mg/d or the individual's best tolerated dose.
Novartis Investigative Site, Beijing
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY